{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:13:58Z","timestamp":1778944438677,"version":"3.51.4"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Subarachnoid hemorrhage (SAH) is a devastating cerebrovascular condition, not only due to the effect of initial hemorrhage, but also due to the complication of delayed cerebral ischemia (DCI). While hypertension facilitated by vasopressors is often initiated to prevent DCI, which vasopressor is most effective in improving outcomes is not known. The objective of this study was to determine associations between initial vasopressor choice and mortality in patients with nontraumatic SAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a retrospective cohort study using a large, national electronic medical record data set from 2000\u20132014 to identify patients with a new diagnosis of nontraumatic SAH (based on ICD-9 codes) who were treated with the vasopressors dopamine, phenylephrine, or norepinephrine. The relationship between the initial choice of vasopressor therapy and the primary outcome, which was defined as in-hospital death or discharge to hospice care, was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In total, 2634 patients were identified with nontraumatic SAH who were treated with a vasopressor. In this cohort, the average age was 56.5 years, 63.9% were female, and 36.5% of patients developed the primary outcome. The incidence of the primary outcome was higher in those initially treated with either norepinephrine (47.6%) or dopamine (50.6%) than with phenylephrine (24.5%). After adjusting for possible confounders using propensity score methods, the adjusted OR of the primary outcome was higher with dopamine (OR 2.19, 95% CI 1.70\u20132.81) and norepinephrine (OR 2.24, 95% CI 1.80\u20132.80) compared with phenylephrine. Sensitivity analyses using different variable selection procedures, causal inference models, and machine-learning methods confirmed the main findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In patients with nontraumatic SAH, phenylephrine was significantly associated with reduced mortality in SAH patients compared to dopamine or norepinephrine. Prospective randomized clinical studies are warranted to confirm this finding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.2.focus191002","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T19:35:47Z","timestamp":1588361747000},"page":"E4","source":"Crossref","is-referenced-by-count":12,"title":["Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysis"],"prefix":"10.3171","volume":"48","author":[{"given":"George","family":"Williams","sequence":"first","affiliation":[{"name":"McGovern Medical School,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahed","family":"Maroufy","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Rasmy","sequence":"additional","affiliation":[{"name":"School of Biomedical Informatics, University of Texas Health Science Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashar","family":"Talebi","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emy","family":"Thomas","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Yaseen","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Miao","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Leon Novelo","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Degui","family":"Zhi","sequence":"additional","affiliation":[{"name":"School of Public Health, and"},{"name":"School of Biomedical Informatics, University of Texas Health Science Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacia M.","family":"DeSantis","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjian","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Miguel","family":"Yamal","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Aguilar","sequence":"additional","affiliation":[{"name":"McGovern Medical School,"},{"name":"School of Public Health, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulin","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health, and"},{"name":"School of Biomedical Informatics, University of Texas Health Science Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"IEEE Trans Automat Contr","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike H","year":"1974","unstructured":"Akaike H: A new look at the statistical model identification. IEEE Trans Automat Contr 19:716\u2013723, 197410.1109\/TAC.1974.1100705"},{"key":"b2","series-title":"Med Decis Making","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0272989X09341755","article-title":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies","volume":"29","author":"Austin PC","year":"2009","unstructured":"Austin PC: The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 29:661\u2013677, 20091968428810.1177\/0272989X09341755"},{"key":"b3","series-title":"Stat Med","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin PC","year":"2015","unstructured":"Austin PC, Stuart EA: Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679, 20152623895810.1002\/sim.6607"},{"key":"b4","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","article-title":"The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage","volume":"85","author":"Budohoski KP","year":"2014","unstructured":"Budohoski KP, Guilfoyle M, Helmy A, Huuskonen T, Czosnyka M, Kirollos R, : The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 85:1343\u20131353, 201410.1136\/jnnp-2014-30771124847164"},{"key":"b5","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly ES Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, : Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 43:1711\u20131737, 20122255619510.1161\/STR.0b013e3182587839"},{"key":"b6","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0150621","DOI":"10.1371\/journal.pone.0150621","article-title":"Associations between anticholinergic burden and adverse health outcomes in Parkinson disease","volume":"11","author":"Crispo JAG","year":"2016","unstructured":"Crispo JAG, Willis AW, Thibault DP, Fortin Y, Hays HD, McNair DS, : Associations between anticholinergic burden and adverse health outcomes in Parkinson disease. PLoS One 11:e0150621, 20162693913010.1371\/journal.pone.0150621"},{"key":"b7","series-title":"J Crit Care","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jcrc.2016.04.004","article-title":"Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: a pilot study","volume":"34","author":"Delgado T","year":"2016","unstructured":"Delgado T, Wolfe B, Davis G, Ansari S: Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: a pilot study. J Crit Care 34:107\u2013110, 201610.1016\/j.jcrc.2016.04.004"},{"key":"b8","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","article-title":"Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference","volume":"15","author":"Diringer MN","year":"2011","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J III, Menon D, Shutter L, Vespa P, : Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference. Neurocrit Care 15:211\u2013240, 20112177387310.1007\/s12028-011-9605-9"},{"key":"b9","series-title":"JAMA Neurol","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","article-title":"Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis","volume":"76","author":"Etminan N","year":"2019","unstructured":"Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, : Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 76:588\u2013597, 20193065957310.1001\/jamaneurol.2019.0006"},{"key":"b10","series-title":"Stat Med","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/sim.4168","article-title":"Generalized propensity score for estimating the average treatment effect of multiple treatments","volume":"31","author":"Feng P","year":"2012","unstructured":"Feng P, Zhou XH, Zou QM, Fan MY, Li XS: Generalized propensity score for estimating the average treatment effect of multiple treatments. Stat Med 31:681\u2013697, 20122135129110.1002\/sim.4168"},{"key":"b11","series-title":"CMAJ","doi-asserted-by":"publisher","first-page":"E1421","DOI":"10.1503\/cmaj.170893","article-title":"Subarachnoid hemorrhage","volume":"189","author":"Fernando SM","year":"2017","unstructured":"Fernando SM, Perry JJ: Subarachnoid hemorrhage. CMAJ 189:E1421, 201710.1503\/cmaj.17089329158456"},{"key":"b12","series-title":"Crit Care","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13054-016-1447-6","article-title":"Management of delayed cerebral ischemia after subarachnoid hemorrhage","volume":"20","author":"Francoeur CL","year":"2016","unstructured":"Francoeur CL, Mayer SA: Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 20:277, 201610.1186\/s13054-016-1447-627737684"},{"key":"b13","series-title":"Biometrika","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","article-title":"The role of the propensity score in estimating dose-response functions","volume":"87","author":"Imbens GW","year":"2000","unstructured":"Imbens GW: The role of the propensity score in estimating dose-response functions. Biometrika 87:706\u2013710, 200010.1093\/biomet\/87.3.706"},{"key":"b14","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1227\/01.NEU.0000088567.59324.78","article-title":"Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow","volume":"53","author":"Joseph M","year":"2003","unstructured":"Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M: Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 53:1044\u20131052, 200310.1227\/01.NEU.0000088567.59324.7814580270"},{"key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/jns.1976.45.2.0148","article-title":"Postoperative hypertension in the management of patients with intracranial arterial aneurysms","volume":"45","author":"Kosnik EJ","year":"1976","unstructured":"Kosnik EJ, Hunt WE: Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45:148\u2013154, 197693997310.3171\/jns.1976.45.2.0148"},{"key":"b16","series-title":"Biomed Res Int 2014","first-page":"679014","article-title":"Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies","author":"Lin CL","year":"2014","unstructured":"Lin CL, Dumont AS, Zhang JH, Zuccarello M, Muroi C: Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies. Biomed Res Int 2014:2014, 679014"},{"key":"b17","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1136\/neurintsurg-2015-012103.rep","article-title":"Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage","volume":"8","author":"Madaelil TP","year":"2016","unstructured":"Madaelil TP, Dhar R: Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage. J Neurointerv Surg 8:e45, 201610.1136\/neurintsurg-2015-012103.rep26683304"},{"key":"b18","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/01.STR.25.11.2315","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association","volume":"25","author":"Mayberg MR","year":"1994","unstructured":"Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, : Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315\u20132328, 1994797456810.1161\/01.STR.25.11.2315"},{"key":"b19","series-title":"Stat Med","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","author":"McCaffrey DF","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF: A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 32:3388\u20133414, 20132350867310.1002\/sim.5753"},{"key":"b20","series-title":"Logistic Regression: From Introductory to Advanced Concepts and Applications","author":"Menard S","year":"2014","unstructured":"Menard S: Logistic Regression: From Introductory to Advanced Concepts and Applications. Thousand Oaks, CA: SAGE Publications, 2014"},{"key":"b21","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12028-010-9437-z","article-title":"Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage","volume":"14","author":"Meyer R","year":"2011","unstructured":"Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM: Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care 14:24\u201336, 201110.1007\/s12028-010-9437-z20838932"},{"key":"b22","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1161\/01.STR.26.12.2260","article-title":"Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage","volume":"26","author":"Miller JA","year":"1995","unstructured":"Miller JA, Dacey RG Jr, Diringer MN: Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 26:2260\u20132266, 199510.1161\/01.STR.26.12.22607491647"},{"key":"b23","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/NCC:6:1:3","article-title":"Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage","volume":"6","author":"Muehlschlegel S","year":"2007","unstructured":"Muehlschlegel S, Dunser MW, Gabrielli A, Wenzel V, Layon AJ: Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Neurocrit Care 6:3\u201310, 200710.1385\/NCC:6:1:317356185"},{"key":"b24","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0090-3019(86)90205-3","article-title":"Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow","volume":"25","author":"Muizelaar JP","year":"1986","unstructured":"Muizelaar JP, Becker DP: Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol 25:317\u2013325, 1986395262410.1016\/0090-3019(86)90205-3"},{"key":"b25","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/00006123-199707000-00029","article-title":"A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series","volume":"41","author":"Oshiro EM","year":"1997","unstructured":"Oshiro EM, Walter KA, Piantadosi S, Witham TF, Tamargo RJ: A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series. Neurosurgery 41:140\u2013148, 199710.1097\/00006123-199707000-00029"},{"key":"b26","series-title":"J R Stat Soc Series B Stat Methodol","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1467-9868.2007.00607.x","article-title":"L1-regularization path algorithm for generalized linear models","volume":"69","author":"Park MY","year":"2007","unstructured":"Park MY, Hastie T: L1-regularization path algorithm for generalized linear models. J R Stat Soc Series B Stat Methodol 69:659\u2013677, 200710.1111\/j.1467-9868.2007.00607.x"},{"key":"b27","series-title":"Intensive Care Med","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s001340000754","article-title":"Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured patients","volume":"27","author":"Ract C","year":"2001","unstructured":"Ract C, Vigu\u00e9 B: Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured patients. Intensive Care Med 27:101\u2013106, 200110.1007\/s00134000075411280619"},{"issue":"11\u201316","key":"b28","series-title":"J Biomed Inform","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2018.06.011","article-title":"A study of generalizability of recurrent neural network-based predictive models for heart failure onset risk using a large and heterogeneous EHR data set","volume":"84","author":"Rasmy L","year":"2018","unstructured":"Rasmy L, Wu Y, Wang N, Geng X, Zheng WJ, Wang F, : A study of generalizability of recurrent neural network-based predictive models for heart failure onset risk using a large and heterogeneous EHR data set. J Biomed Inform 84:11\u201316, 20182990890210.1016\/j.jbi.2018.06.011"},{"key":"b29","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3171\/2014.12.JNS141201","article-title":"The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms","volume":"123","author":"Reynolds MR","year":"2015","unstructured":"Reynolds MR, Buckley RT, Indrakanti SS, Turkmani AH, Oh G, Crobeddu E, : The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms. J Neurosurg 123:862\u2013871, 201510.3171\/2014.12.JNS14120126207606"},{"key":"b30","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1385\/NCC:1:3:287","article-title":"Optimizing blood pressure in neurological emergencies","volume":"1","author":"Rose JC","year":"2004","unstructured":"Rose JC, Mayer SA: Optimizing blood pressure in neurological emergencies. Neurocrit Care 1:287\u2013299, 2004 (Erratum in Neurocrit Care 4:98, 2006)1617492610.1385\/NCC:1:3:287"},{"key":"b31","series-title":"Biometrika","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum PR","year":"1983","unstructured":"Rosenbaum PR: Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70:41\u201355, 198310.1093\/biomet\/70.1.41"},{"key":"b32","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000458536","article-title":"Comparison of initial vasopressors used for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"43","author":"Roy B","year":"2017","unstructured":"Roy B, McCullough LD, Dhar R, Grady J, Wang YB, Brown RJ: Comparison of initial vasopressors used for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 43:266\u2013271, 201710.1159\/00045853628319954"},{"issue":"25","key":"b33","series-title":"Ann Intensive Care","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0128-6","article-title":"Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension","volume":"6","author":"Sakr Y","year":"2016","unstructured":"Sakr Y, D\u00fcnisch P, Santos C, Matthes L, Zeidan M, Reinhart K, : Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension. Ann Intensive Care 6:25, 201610.1186\/s13613-016-0128-627033710"},{"key":"b34","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1227\/01.neu.0000306090.30517.ae","article-title":"Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003","volume":"61","author":"Shea AM","year":"2007","unstructured":"Shea AM, Reed SD, Curtis LH, Alexander MJ, Villani JJ, Schulman KA: Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery 61:1131\u20131138, 200710.1227\/01.neu.0000306090.30517.ae18162891"},{"key":"b35","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12028-011-9602-z","article-title":"High-volume centers","volume":"15","author":"Vespa P","year":"2011","unstructured":"Vespa P, Diringer MN: High-volume centers. Neurocrit Care 15:369\u2013372, 20112179275410.1007\/s12028-011-9602-z"},{"key":"b36","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fneur.2017.00424","article-title":"Decreasing risk of fatal subarachnoid hemorrhage and other epidemiological trends in the era of coiling implementation in Australia","volume":"8","author":"Worthington JM","year":"2017","unstructured":"Worthington JM, Goumas C, Jalaludin B, Gattellari M: Decreasing risk of fatal subarachnoid hemorrhage and other epidemiological trends in the era of coiling implementation in Australia. Front Neurol 8:424, 20172891274710.3389\/fneur.2017.00424"},{"key":"b37","series-title":"Int J Surg","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijsu.2017.11.033","article-title":"Timing of surgery for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"48","author":"Yao Z","year":"2017","unstructured":"Yao Z, Hu X, Ma L, You C, He M: Timing of surgery for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Int J Surg 48:266\u2013274, 201710.1016\/j.ijsu.2017.11.03329180068"},{"key":"b38","series-title":"Neurosurg Clin N Am","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nec.2009.10.002","article-title":"Epidemiology of aneurysmal subarachnoid hemorrhage","volume":"21","author":"Zacharia BE","year":"2010","unstructured":"Zacharia BE, Hickman ZL, Grobelny BT, DeRosa P, Kotchetkov I, Ducruet AF, : Epidemiology of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 21:221\u2013233, 20102038096510.1016\/j.nec.2009.10.002"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/5\/article-pE4.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/5\/article-pE4.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/48\/5\/article-pE4.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:38:38Z","timestamp":1778315918000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/48\/5\/article-pE4.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":38,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2020.2.focus191002","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}